PacBio to Report Q4 and Full Year 2025 Results on February 12

Got story updates? Submit your updates here. ›

PacBio, a leading life science technology company, announced that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time. The call will be webcast and may be accessed on the company's investor relations website.

Why it matters

As a major player in the genomics and sequencing technology space, PacBio's financial performance and outlook are closely watched by investors and industry analysts. The company's results and commentary on the call will provide insights into the broader trends and challenges facing the life sciences sector.

The details

PacBio designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The company's products and technologies, including its HiFi long-read sequencing, address a wide range of research applications such as human germline sequencing, plant and animal sciences, infectious disease, oncology, and other emerging areas.

• The conference call will be held on Thursday, February 12, 2026, at 5:00 pm Eastern Time (2:00 pm Pacific Time).

What’s next

Investors and analysts will be closely watching PacBio's conference call on February 12, 2026, for insights into the company's financial performance, market trends, and future outlook.